🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Coloplast A/S (CPH:COLO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
505.20
+5.70 (1.14%)
Nov 20, 2026, 11:21 AM CET

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of DKK 113.75 billion. The enterprise value is 134.76 billion.

Market Cap113.75B
Enterprise Value 134.76B

Important Dates

The last earnings date was Tuesday, November 3, 2026.

Earnings Date Nov 3, 2026
Ex-Dividend Date May 18, 2026

Share Statistics

Coloplast has 225.17 million shares outstanding.

Current Share Class 207.17M
Shares Outstanding 225.17M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.09%
Owned by Insiders (%) 5.25%
Owned by Institutions (%) 35.86%
Float 144.57M

Valuation Ratios

The trailing PE ratio is 37.04 and the forward PE ratio is 19.99. Coloplast's PEG ratio is 3.51.

PE Ratio 37.04
Forward PE 19.99
PS Ratio 3.93
PB Ratio 7.96
P/TBV Ratio n/a
P/FCF Ratio 17.19
P/OCF Ratio 14.21
PEG Ratio 3.51
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.47, with an EV/FCF ratio of 20.36.

EV / Earnings 43.85
EV / Sales 4.66
EV / EBITDA 15.47
EV / EBIT 18.10
EV / FCF 20.36

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 1.51.

Current Ratio 0.74
Quick Ratio 0.41
Debt / Equity 1.51
Debt / EBITDA 2.47
Debt / FCF 3.25
Interest Coverage 11.32

Financial Efficiency

Return on equity (ROE) is 20.21% and return on invested capital (ROIC) is 16.60%.

Return on Equity (ROE) 20.21%
Return on Assets (ROA) 6.50%
Return on Invested Capital (ROIC) 16.60%
Return on Capital Employed (ROCE) 22.70%
Weighted Average Cost of Capital (WACC) 6.59%
Revenue Per Employee 1.68M
Profits Per Employee 177,997
Employee Count17,270
Asset Turnover 0.61
Inventory Turnover 2.43

Taxes

In the past 12 months, Coloplast has paid 775.00 million in taxes.

Income Tax 775.00M
Effective Tax Rate 20.14%

Stock Price Statistics

The stock price has decreased by -13.49% in the last 52 weeks. The beta is 0.57, so Coloplast's price volatility has been lower than the market average.

Beta (5Y) 0.57
52-Week Price Change -13.49%
50-Day Moving Average 458.34
200-Day Moving Average 435.86
Relative Strength Index (RSI) 57.61
Average Volume (20 Days) 438,677

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Coloplast had revenue of DKK 28.94 billion and earned 3.07 billion in profits. Earnings per share was 13.64.

Revenue28.94B
Gross Profit 19.25B
Operating Income 7.45B
Pretax Income 3.85B
Net Income 3.07B
EBITDA 8.42B
EBIT 7.45B
Earnings Per Share (EPS) 13.64
Full Income Statement

Balance Sheet

The company has 511.00 million in cash and 21.52 billion in debt, with a net cash position of -21.01 billion or -93.29 per share.

Cash & Cash Equivalents 511.00M
Total Debt 21.52B
Net Cash -21.01B
Net Cash Per Share -93.29
Equity (Book Value) 14.29B
Book Value Per Share 63.42
Working Capital -3.51B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.01 billion and capital expenditures -1.39 billion, giving a free cash flow of 6.62 billion.

Operating Cash Flow 8.01B
Capital Expenditures -1.39B
Depreciation & Amortization 969.00M
Net Borrowing -1.57B
Free Cash Flow 6.62B
FCF Per Share 29.40
Full Cash Flow Statement

Margins

Gross margin is 66.50%, with operating and profit margins of 25.73% and 10.62%.

Gross Margin 66.50%
Operating Margin 25.73%
Pretax Margin 13.30%
Profit Margin 10.62%
EBITDA Margin 29.08%
EBIT Margin 25.73%
FCF Margin 22.87%

Dividends & Yields

This stock pays an annual dividend of 23.00, which amounts to a dividend yield of 4.55%.

Dividend Per Share 23.00
Dividend Yield 4.55%
Dividend Growth (YoY) 4.55%
Years of Dividend Growth 17
Payout Ratio 36.63%
FCF Payout Ratio 78.23%
Buyback Yield n/a
Shareholder Yield 4.55%
Earnings Yield 2.70%
FCF Yield 5.82%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for Coloplast is 473.81, which is -6.21% lower than the current price. The consensus rating is "Hold".

Price Target 473.81
Price Target Difference -6.21%
Analyst Consensus Hold
Analyst Count 21
Revenue Growth Forecast (3Y) 6.77%
EPS Growth Forecast (3Y) 5.56%

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date Dec 19, 2012
Split Type Forward
Split Ratio 5

Scores

Coloplast has an Altman Z-Score of 3.56 and a Piotroski F-Score of 6.

Altman Z-Score 3.56
Piotroski F-Score 6